Home / Health / Shingles Jab Halves Heart Attack Risk
Shingles Jab Halves Heart Attack Risk
17 Mar
Summary
- Shingles vaccine significantly reduces heart attack and stroke risk.
- Vaccine may prevent blood clots linked to shingles infections.
- Study shows 46% lower risk of major cardiac events post-vaccination.
A cost-effective shingles vaccine, readily accessible through the NHS, has demonstrated the potential to reduce the risk of heart attack and stroke by as much as 50%. Scientific findings presented at the American College of Cardiology's Annual Scientific Session indicate a significant cardioprotective benefit for adults, particularly those with existing cardiovascular disease.
The research analyzed health records of nearly 250,000 Americans, comparing vaccinated individuals with a control group. Those who received the shingles vaccine, such as Shingrix or Zostavax, exhibited a markedly lower incidence of major cardiac events within a year of vaccination. This included a 32% reduction in heart attack risk and a 25% decrease in stroke occurrences.
Scientists suggest the vaccine might counteract the formation of blood clots, which can be triggered by shingles infections and lead to serious cardiovascular events like heart attacks and strokes. The study's lead author highlighted that these protective effects are comparable to quitting smoking, reinforcing recommendations for vaccination in adults over 50. While acknowledging potential confounding factors like healthier lifestyles among the vaccinated, the findings add compelling evidence to the vaccine's multifaceted health benefits beyond preventing shingles.
